Harnessing Genomics and Molecular Profiling in ER-Positive BC for New Therapies

Article Figures & Data

Figures

  • Figure 1.

    Functional and Therapeutic Map of Gene Mutations to Guide Drug Development

    HER2, human epidermal growth factor receptor 2; PI3K, phosphatidylinositol-3-kinase; RTK, receptor tyrosine kinase.

    Adapted from Cancer Discovery, Copyright 2013;3:27–34, Ellis MJ et al. The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap. With permission from AACR.